Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex

NCT01081509 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01081509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01081509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
October 31, 2011
Enrollment
1,077 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer